Psyence Biomedical Ltd. Warrant (PBMWW)

Price$0.04

Favorite Metrics

Price vs S&P 500 (26W)24.07%

Price vs S&P 500 (4W)81.62%

All Metrics

Price vs S&P 500 (YTD)82.63%

10-Day Avg Trading Volume0.12M

3-Month Avg Trading Volume0.04M

52-Week High$0.09

26-Week Price Return32.82%

13-Week Price Return92.18%

3-Month Return Std Dev279.65%

Year-to-Date Return84.95%

5-Day Price Return90.06%

Month-to-Date Return89.01%

Price vs S&P 500 (13W)89.31%

Beta0.28x

52-Week Low$0.01

About

Psyence Biomedical develops natural psilocybin products for treating psychological trauma and mental health conditions in palliative care, currently advancing candidates through clinical trials. The company operates a federally licensed cultivation facility in Southern Africa, producing and exporting psilocybin for standardized pharmaceutical processing by international partners. This positions the company at the intersection of emerging psychedelic therapeutics and regulated mental health treatment markets.